In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more ...
Kaitlin Sullivan is a health and science journalist based in Colorado. She's been part of multiple award-winning investigations into health topics including the international medical device industry ...
This guide was reviewed by a Business News Daily editor to ensure it provides comprehensive and accurate information to aid your buying decision. Modern businesses run on data. Companies regularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback